drugset / Trial / NCT04380233
Zhizhu Kuanzhong Capsule for Patients With Functional Dyspepsia-Postprandial Distress Syndrome
Unknown
60 enrolled
Hong Kong Baptist University
Xiyuan Hospital of China Academy of Chinese Medical Sciences · collab
RandomizedParallel-groupTriple-blindTreatment
Summary
A 13 weeks randomized, double-blind and placebo parallel-controlled trial will be conducted to evaluate the clinical efficacy and safety of Zhizhu Kuanzhong Capsule in the treatment of functional dyspepsia-postprandial distress syndrome.
Timeline
- Start
- 2021-04-01
- Primary completion
- 2022-02-28
- Completion
- 2022-03-30
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Zhizhu Kuanzhong Capsule | Traditional medicine (herbal / TCM) | 1.29 g | Oral |